Crossmark

Analytical validity of DecisionDx-SCC, a gene expression profile test to identify risk of metastasis in cutaneous squamous cell carcinoma (SCC) patients

Crossref DOI link: https://doi.org/10.1186/s13000-022-01211-w

Published Online: 2022-02-25

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Borman, Sherri

Wilkinson, Jeff

Meldi-Sholl, Lauren

Johnson, Clare

Carter, Kelsey

Covington, Kyle R.

Fitzgerald, Alison L.

Kurley, Sarah J.

Farberg, Aaron S.

Goldberg, Matthew S.

Monzon, Federico A.

Oelschlager, Kristen

Cook, Robert W. http://orcid.org/0000-0003-1166-4796
Funding

Funding for this research was provided by:

Castle Biosciences, Inc.
License Information

Text and Data Mining valid from 2022-02-25

Version of Record valid from 2022-02-25
More Information

Article History

Received: 18 October 2021

Accepted: 25 January 2022

First Online: 25 February 2022

Declarations

:

: N/A

: N/A

: Authors are/have been employees of Castle Biosciences, Inc. and hold stock in the company.

Document is current

Any future updates will be listed below